Intravitreal anti-vascular endothelial growth factor therapy with pegaptanib for advanced von Hippel-Lindau disease of the retina.
about
An Update on the Ophthalmologic Features in the PhakomatosesDevelopment of the anti-VEGF aptamer to a therapeutic agent for clinical ophthalmology.Indirect laser treatment and anti-VEGF therapy of a retinal angioma, with resolution of a large serous retinal detachment, macular exudates, and macular edema.Long-term use of intravitreal bevacizumab (avastin) for the treatment of von hippel-lindau associated retinal hemangioblastomasSubretinal hemorrhage after photodynamic therapy for juxtapapillary retinal capillary hemangiomaPilot trial of sunitinib therapy in patients with von Hippel-Lindau diseaseOcular von Hippel-Lindau disease: clinical update and emerging treatments.Intravitreal ranibizumab therapy for retinal capillary hemangioblastoma related to von Hippel-Lindau disease.Vitrectomy for Tractional Retinal Detachment with Twin Retinal Capillary Hemangiomas in a Patient with Von Hippel-Lindau Disease: A Case Report.An electronic medical records system for clinical research and the EMR EDC interface.Intravitreal anti-VEGF injection for the treatment of progressive juxtapapillary retinal capillary hemangioma: a case report and mini review of the literature.Photodynamic therapy for juxtapapillary retinal capillary hemangioma.Use of intravitreal bevacizumab in a patient with a Von Hippel-Lindau-associated retinal haemangioblastoma of the optic nerve head: a case reportAngiogenesis biomarkers and their targeting ligands as potential targets for tumor angiogenesis.Brachytherapy for benign fundus lesions
P2860
Q26738915-E18AA6AA-3F1B-4A24-BE27-D7789B78CF31Q33492343-1BB779C7-5462-4B99-AF7F-4351C1B156C4Q33589141-FFD646A3-EE72-4A9B-86A6-122C86189166Q33811756-B0222B17-9B94-4677-B616-F6B5309239AFQ33903891-174D1D61-DD73-4D3F-B12B-71BE0C8E7D9CQ34079864-765925EE-7177-44E1-A27B-5A0C7DECA09EQ34459992-0BA34B8B-FAC3-4F51-8506-C7EDD5D096D8Q34554270-43CC58C2-B237-43E2-AA3F-2891ABB04619Q36086912-9EBA39F1-3BB0-48A8-9984-87D8FDF600F9Q36614548-7C6D3DD3-7372-49ED-BF87-2C00B12C777FQ38160832-762ACF84-D80E-413E-A111-70127422200BQ38578028-3E3AE752-6806-43AB-942A-49599246A45BQ39245217-E71C4715-AD7E-4B9F-A44D-5FCCCDEF0E29Q39368829-A5BCB8A3-1918-4850-BC1A-8BC732E19745Q58494255-34DF3B4C-23EA-47C5-81EF-AB8AC6DF2112
P2860
Intravitreal anti-vascular endothelial growth factor therapy with pegaptanib for advanced von Hippel-Lindau disease of the retina.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Intravitreal anti-vascular end ...... -Lindau disease of the retina.
@en
Intravitreal anti-vascular end ...... -Lindau disease of the retina.
@nl
type
label
Intravitreal anti-vascular end ...... -Lindau disease of the retina.
@en
Intravitreal anti-vascular end ...... -Lindau disease of the retina.
@nl
prefLabel
Intravitreal anti-vascular end ...... -Lindau disease of the retina.
@en
Intravitreal anti-vascular end ...... -Lindau disease of the retina.
@nl
P2093
P1433
P1476
Intravitreal anti-vascular end ...... -Lindau disease of the retina.
@en
P2093
Darby J Thompson
Frederick L Ferris
Hanna Rodriguez-Coleman
Michael Cusick
Sam S Dahr
Sunil K Srivastava
W Marston Linehan
P304
P356
10.1097/IAE.0B013E318030A290
P50
P577
2007-02-01T00:00:00Z